|
1
|
Sun X, Chen W, Chen Z, Wen D, Zhao D and
He Y: Population-based case-control study on risk factors for
esophageal cancer in five high-risk areas in China. Asian Pac J
Cancer Prev. 11:1631–1636. 2010.
|
|
2
|
Hongo M, Nagasaki Y and Shoji T:
Epidemiology of esophageal cancer: Orient to Occident. Effects of
chronology, geography and ethnicity. J Gastroenterol Hepatol.
24:729–735. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Song Q, Liu H, Wang J, Jia Y, Liu Y, Wang
N, Tan B, Guan S, An D and Cheng Y: Dinner-to-bed time and
post-dinner walk: New potential independent factors in esophageal
cancer development. J Cancer Res Clin Oncol. 140:817–821. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jemal A, Center MM, DeSantis C and Ward
EM: Global patterns of cancer incidence and mortality rates and
trends. Cancer Epidemiol Biomarkers Prev. 19:1893–1907. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tang WR, Fang JY, Wu KS, Shi XJ, Luo JY
and Lin K: Epidemiological characteristics and prediction of
esophageal cancer mortality in China from 1991 to 2012. Asian Pac J
Cancer Prev. 15:6929–6934. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Louro R, Smirnova AS and Verjovski-Almeida
S: Long intronic noncoding RNA transcription: Expression noise or
expression choice? Genomics. 93:291–298. 2009. View Article : Google Scholar
|
|
7
|
Herriges MJ, Swarr DT, Morley MP, Rathi
KS, Peng T, Stewart KM and Morrisey EE: Long noncoding RNAs are
spatially correlated with transcription factors and regulate lung
development. Genes Dev. 28:1363–1379. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hu X, Feng Y, Zhang D, Zhao SD, Hu Z,
Greshock J, Zhang Y, Yang L, Zhong X, Wang LP, et al: A functional
genomic approach identifies FAL1 as an oncogenic long noncoding RNA
that associates with BMI1 and represses p21 expression in cancer.
Cancer Cell. 26:344–357. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yuan JH, Yang F, Wang F, Ma JZ, Guo YJ,
Tao QF, Liu F, Pan W, Wang TT, Zhou CC, et al: A long noncoding RNA
activated by TGF-β promotes the invasion-metastasis cascade in
hepatocellular carcinoma. Cancer Cell. 25:666–681. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cui M, Xiao Z, Wang Y, Zheng M, Song T,
Cai X, Sun B, Ye L and Zhang X: Long noncoding RNA HULC modulates
abnormal lipid metabolism in hepatoma cells through an
miR-9-mediated RXRA signaling pathway. Cancer Res. 75:846–857.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Rühle F and Stoll M: Long non-coding RNA
databases in cardiovascular research. Genomics Proteomics
Bioinformatics. 14:191–199. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yang C, Wu D, Gao L, Liu X, Jin Y, Wang D,
Wang T and Li X: Competing endogenous RNA networks in human cancer:
Hypothesis, validation, and perspectives. Oncotarget.
7:13479–13490. 2016.PubMed/NCBI
|
|
13
|
Liu X, Xiao ZD, Han L, Zhang J, Lee SW,
Wang W, Lee H, Zhuang L, Chen J, Lin HK, et al: LncRNA NBR2 engages
a metabolic checkpoint by regulating AMPK under energy stress. Nat
Cell Biol. 18:431–442. 2016. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu F, Yuan JH, Huang JF, Yang F, Wang TT,
Ma JZ, Zhang L, Zhou CC, Wang F, Yu J, et al: Long noncoding RNA
FTX inhibits hepatocellular carcinoma proliferation and metastasis
by binding MCM2 and miR-374a. Oncogene. Apr 11–2016. View Article : Google Scholar
|
|
15
|
Chen M, Zhuang C, Liu Y, Li J, Dai F, Xia
M, Zhan Y, Lin J, Chen Z, He A, et al: Tetracycline-inducible shRNA
targeting antisense long non-coding RNA HIF1A-AS2 represses the
malignant phenotypes of bladder cancer. Cancer Lett. 376:155–164.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bian Z, Jin L, Zhang J, Yin Y, Quan C, Hu
Y, Feng Y, Liu H, Fei B, Mao Y, et al: LncRNA-UCA1 enhances cell
proliferation and 5-fluorouracil resistance in colorectal cancer by
inhibiting miR-204–5p. Sci Rep. 6:238922016. View Article : Google Scholar
|
|
17
|
Hu JJ, Song W, Zhang SD, Shen XH, Qiu XM,
Wu HZ, Gong PH, Lu S, Zhao ZJ, He ML, et al: HBx-upregulated lncRNA
UCA1 promotes cell growth and tumorigenesis by recruiting EZH2 and
repressing p27Kip1/CDK2 signaling. Sci Rep. 6:235212016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gu W, Gao T, Sun Y, Zheng X, Wang J, Ma J,
Hu X, Li J and Hu M: LncRNA expression profile reveals the
potential role of lncRNAs in gastric carcinogenesis. Cancer
Biomark. 15:249–258. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wu W, Zhang S, Li X, Xue M, Cao S and Chen
W: Ets-2 regulates cell apoptosis via the Akt pathway, through the
regulation of urothelial cancer associated 1, a long non-coding
RNA, in bladder cancer cells. PLoS One. 8:e739202013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Fan Y, Shen B, Tan M, Mu X, Qin Y, Zhang F
and Liu Y: Long non-coding RNA UCA1 increases chemoresistance of
bladder cancer cells by regulating Wnt signaling. FEBS J.
281:1750–1758. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li Z, Li X, Wu S, Xue M and Chen W: Long
non-coding RNA UCA1 promotes glycolysis by upregulating hexokinase
2 through the mTOR-STAT3/microRNA143 pathway. Cancer Sci.
105:951–955. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Du Z, Sun T, Hacisuleyman E, Fei T, Wang
X, Brown M, Rinn JL, Lee MG, Chen Y, Kantoff PW, et al: Integrative
analyses reveal a long noncoding RNA-mediated sponge regulatory
network in prostate cancer. Nat Commun. 7:109822016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yu CC, Chen PN, Peng CY, Yu CH and Chou
MY: Suppression of miR-204 enables oral squamous cell carcinomas to
promote cancer stemness, EMT traits, and lymph node metastasis.
Oncotarget. 7:20180–20192. 2016.PubMed/NCBI
|
|
24
|
Ying Z, Li Y, Wu J, Zhu X, Yang Y, Tian H,
Li W, Hu B, Cheng SY and Li M: Loss of miR-204 expression enhances
glioma migration and stem cell-like phenotype. Cancer Res.
73:990–999. 2013. View Article : Google Scholar :
|
|
25
|
Liu J and Sun X, Zhu H, Qin Q, Yang X and
Sun X: Long noncoding RNA POU6F2-AS2 is associated with esophageal
squamous cell carcinoma. J Biochem. Mar 31–2016.(Epub ahead of
print) pii: mvw025.
|
|
26
|
Li W, Zheng J, Deng J, You Y, Wu H, Li N,
Lu J and Zhou Y: Increased levels of the long intergenic
non-protein coding RNA POU3F3 promote DNA methylation in esophageal
squamous cell carcinoma cells. Gastroenterology. 146:1714–1726.e5.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liu Z, Long J, Du R, Ge C, Guo K and Xu Y:
miR-204 regulates the EMT by targeting snai1 to suppress the
invasion and migration of gastric cancer. Tumour Biol.
37:8327–8335. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wu ZY, Wang SM, Chen ZH, Huv SX, Huang K,
Huang BJ, Du JL, Huang CM, Peng L, Jian ZX, et al: MiR-204
regulates HMGA2 expression and inhibits cell proliferation in human
thyroid cancer. Cancer Biomark. 15:535–542. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ding M, Lin B, Li T, Liu Y, Li Y, Zhou X,
Miao M, Gu J, Pan H, Yang F, et al: A dual yet opposite
growth-regulating function of miR-204 and its target XRN1 in
prostate adenocarcinoma cells and neuroendocrine-like prostate
cancer cells. Oncotarget. 6:7686–7700. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yang Y, Jiang Y, Wan Y, Zhang L, Qiu J,
Zhou S and Cheng W: UCA1 functions as a competing endogenous RNA to
suppress epithelial ovarian cancer metastasis. Tumour Biol. Feb
11–2016.Epub ahead of print.
|
|
31
|
Nie W, Ge HJ, Yang XQ, Sun X, Huang H, Tao
X, Chen WS and Li B: LncRNA-UCA1 exerts oncogenic functions in
non-small cell lung cancer by targeting miR-193a-3p. Cancer Lett.
371:99–106. 2016. View Article : Google Scholar
|
|
32
|
Xue M, Pang H, Li X, Li H, Pan J and Chen
W: Long non-coding RNA urothelial cancer-associated 1 promotes
bladder cancer cell migration and invasion by way of the
hsa-miR-145-ZEB1/2-FSCN1 pathway. Cancer Sci. 107:18–27. 2016.
View Article : Google Scholar
|
|
33
|
Ye X and Weinberg RA:
Epithelial-mesenchymal plasticity: A central regulator of cancer
progression. Trends Cell Biol. 25:675–686. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Bilir B, Osunkoya AO, Wiles WG IV,
Sannigrahi S, Lefebvre V, Metzger D, Spyropoulos DD, Martin WD and
Moreno CS: SOX4 is essential for prostate tumorigenesis initiated
by PTEN ablation. Cancer Res. 76:1112–1121. 2016. View Article : Google Scholar
|
|
35
|
Sun R, Jiang B, Qi H, Zhang X, Yang J,
Duan J, Li Y and Li G: SOX4 contributes to the progression of
cervical cancer and the resistance to the chemotherapeutic drug
through ABCG2. Cell Death Dis. 6:e19902015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Koumangoye RB, Andl T, Taubenslag KJ,
Zilberman ST, Taylor CJ, Loomans HA and Andl CD: SOX4 interacts
with EZH2 and HDAC3 to suppress microRNA-31 in invasive esophageal
cancer cells. Mol Cancer. 14:242015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Hu F, Min J, Cao X, Liu L, Ge Z, Hu J and
Li X: MiR-363-3p inhibits the epithelial-to-mesenchymal transition
and suppresses metastasis in colorectal cancer by targeting Sox4.
Biochem Biophys Res Commun. 474:35–42. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhang F, Luo Y, Shao Z, Xu L, Liu X, Niu
Y, Shi J, Sun X, Liu Y, Ding Y, et al: MicroRNA-187, a downstream
effector of TGFβ pathway, suppresses Smad-mediated
epithelial-mesenchymal transition in colorectal cancer. Cancer
Lett. 373:203–213. 2016. View Article : Google Scholar : PubMed/NCBI
|
